Should gastroprotective agents be given with COX-2 inhibitors? A question worthy of scrutiny

被引：4

作者：

Bertin, P ^{[1
]}

机构：

[1] CHU Dupuytren, Dupuytren Teaching Hosp, Rheumatol & Therapeut Unit, F-87042 Limoges, France

来源：

JOINT BONE SPINE | 2004年 / 71卷 / 06期

关键词：

COX-2; inhibitors; gastroprotective agents;

D O I：

10.1016/j.jbspin.2004.01.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：454 / 456

页数：3

共 17 条

[1]

AVOUAC B, 2002, PROTECTION DIGESTIVE, P75

[2] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[3]

CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531

[4] Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis [J].

Chan, FKL ;

Hung, LCT ;

Suen, BY ;

Wu, JCY ;

Lee, KC ;

Leung, VKS ;

Hui, AJ ;

To, KF ;

Leung, WK ;

Wong, VWS ;

Chung, SCS ;

Sung, JJY .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) :2104-2110

[5]

Ehrich EW, 1999, J RHEUMATOL, V26, P2438

[6]

FAGGIONATO D, 2002, B INFORMATION EC SAN, V12, P1

[7] NS-398, A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG WITH POTENT ANALGESIC AND ANTIPYRETIC EFFECTS, WHICH CAUSES MINIMAL STOMACH LESIONS [J].

FUTAKI, N ;

YOSHIKAWA, K ;

HAMASAKA, Y ;

ARAI, I ;

HIGUCHI, S ;

IIZUKA, H ;

OTOMO, S .

GENERAL PHARMACOLOGY, 1993, 24 (01) :105-110

[8]

Geis GS, 1999, ARTHRITIS RHEUM, V42, pS144

[9] Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis [J].

Laine, L ;

Bombardier, C ;

Hawkey, CJ ;

Davis, B ;

Shapiro, D ;

Brett, C ;

Reicin, A .

GASTROENTEROLOGY, 2002, 123 (04) :1006-1012

[10] Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen [J].

Lanza, FL ;

Rack, MF ;

Simon, TJ ;

Quan, H ;

Bolognese, JA ;

Hoover, ME ;

Wilson, FR ;

Harper, SE .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (06) :761-767

← 1 2 →